Novavax Succeeds In Phase III Flu Vaccine Trial Against Sanofi’s Fluzone

 
• By Joseph Haas
  
Injection
Novavax Phase III data may position it to file seasonal flu vaccine at FDA this year
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D